Premium Information is available for this item - Upgrade for $1 a day
6505-01-051-6513
Usp Levothyroxine Sodium Tablets
6505010516513 010516513 3P1063 SYNTHROID
INC: 26040 Levothyroxine Sodium Tablets
November 2023
10
Marketplace 6505-01-051-6513
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-051-6513 5+ Documents (More...)
RQST NE Updated Every Day 6505-01-051-6513 RQST Updated Every Day 6505-01-051-6513 RQST NE Related Documents
6505-01-051-6513 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-051-6513
Usp Levothyroxine Sodium Tablets 010516513 your Account Upgrade 6505-01-051-6513Usp Levothyroxine
Sodium Tablets6505010516513 010516513 3P1063 SYNTHROID web browser . 6505-21-908-1819Usp Levothyroxine
web browser . 6505-21-908-1822Usp Levothyroxine Sodium Tablets6505219081822 219081822 DIN 786578 SYNTHROID
Usp Levothyroxine Sodium Tablets 010516513 your Account Upgrade 6505-01-051-6513Usp Levothyroxine
www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-027-9055 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-051-6513
Usp Levothyroxine Sodium Tablets 010516513 your Account Upgrade 6505-01-051-6513Usp Levothyroxine
Sodium Tablets6505010516513 010516513 3P1063 SYNTHROID your Account Upgrade 6505-01-051-6516Usp Levothyroxine
Sodium Tablets6505010516516 010516516 3P1163 SYNTHROID web browser . 6505-21-908-1822Usp Levothyroxine
Restrictions 6505-01-051-6513
6505-01-051-6513 is a Usp Levothyroxine Sodium Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
End Users 6505-01-051-6513
- NASA (G57V)
- Effective Date:
- 1 Apr 1991
- United States of America (ZZ)
Approved Sources 6505-01-051-6513
- Part Number
- Manufacturer
- Status
- 3P1063
- Manufacturer
- 04687 - Baxter Healthcare Corp (Active)
- Incomplete Reference
- Incomplete Reference
- SYNTHROID
- 04687 - Baxter Healthcare Corp (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-051-6513
- Characteristic
- Specifications
- Active Medicament Medicinal Strength [AKJA]
- Specifications
- 0.100 Milligrams Levothyroxine Sodium Active Ingredient
- Primary Container Type [CQCT]
- Strip
- Primary Container Content Quantity [CRLK]
- 10.000 Tablets
- Total Primary Container Quantity [CSCW]
- 10
Similar Supply Items to 6505-01-051-6513
Freight Information 6505-01-051-6513
6505-01-051-6513 has freight characteristics.. 6505-01-051-6513 has a variance between NMFC and UFC when transported by rail and the description should be consulted.